Simultaneous determination of mycophenolate and its metabolite mycophenolate-7-o-glucuronide with an isocratic HPLC-UV-based method in human plasma and stability evaluation

References

• Staatz CE, Tett SE. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients. Clin Pharmacokinet 2007;46:13–58.
   PubMed Web of Science ®Google Scholar
• Schütz E, Shipkova M, Armstrong VW, Wieland E, Oellerich M. Identification of a pharmacologically active metabolite of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil. Clin Chem 1999;45:419–22.
   PubMed Web of Science ®Google Scholar
• Kuypers DRJ, Meur YL, Cantarovich M, Tredger MJ, Tett SE, Cattaneo D, Tönshoff B, Holt DW, Chapman J, Gelder T. Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation. Clin J Am Soc Nephrol 2010;5:341–58.
   PubMed Web of Science ®Google Scholar
• Jain A, Venkataramanan R, Hamad IS, Zuckerman S, Zhang S, Lever J, Warty VS, Fung JJ. Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus. J Clin Pharm 2001;41:268–76.
   PubMed Web of Science ®Google Scholar
• Elbarbry FA, Shoker AS. Therapeutic drug measurement of mycophenolic acid derivatives in transplant patients. Clin Biochem 2007;40:752–64.
   PubMed Web of Science ®Google Scholar
• Shipkova M, Niedmann PD, Armstrong VW, Schütz E, Wieland E, Shaw LM, Oellerich M. Simultaneous determination of mycophenolic acid and its glucuronide in human plasma using a simple high-performance liquid chromatography procedure. Clin Chem 1998;44:1481–8.
   PubMed Web of Science ®Google Scholar
• Bolon M, Jeanpierre L, El Barkil M, Chelbi K, Sauviat M, Boulieu R. HPLC determination of mycophenolic acid and mycophenolic acid glucuronide in human plasma with hybrid material. J Pharm Biomed Anal 2004;36:649–51.
   PubMed Web of Science ®Google Scholar
• Patel CG, Mendonza AE, Akhlaghi F, Majid O, Trull AK, Lee T, Holt DW. Determination of total mycophenolic acid and its glucuronide metabolite using liquid chromatography with ultraviolet detection and unbound mycophenolic acid using tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2004;813:287–94.
   PubMed Web of Science ®Google Scholar
• Yau W-P, Vathsala A, Lou H-X, Chan E. Simple reversed-phase ion-pair liquid chromatography assay for the simultaneous determination of mycophenolic acid and its glucuronide metabolite in human plasma and urine. J Chromatogr B Analyt Technol Biomed Life Sci 2004;805:101–12.
   PubMed Web of Science ®Google Scholar
• Hosotsubo H, Takahara S, Kokado Y, Permpongkosol S, Wang JD, Tanaka T, Matsumiya K, Kitamura M, Okuyama A, Sugimoto H. Rapid and simultaneous determination of mycophenolic acid and its glucuronide conjugate in human plasma by ion-pair reversed-phase high-performance liquid chromatography using isocratic elution. J Chromatogr B Biomed Sci Appl 2001;753:315–20.
   PubMed Web of Science ®Google Scholar
• Wiwattanawongsa K, Heinzen EL, Kemp DC, Dupuis RE, Smith PC. Determination of mycophenolic acid and its phenol glucuronide metabolite in human plasma and urine by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 2001;763:35–45.
   PubMed Web of Science ®Google Scholar
• Bahrami G, Mohammadi B. An isocratic high performance liquid chromatographic method for quantification of mycophenolic acid and its glucuronide metabolite in human serum using liquid-liquid extraction: application to human pharmacokinetic studies. Clin Chim Acta 2006;370:185–90.
   PubMed Web of Science ®Google Scholar
• Annesley TM, Clayton LT. Quantification of mycophenolic acid and glucuronide metabolite in human serum by HPLC-tandem mass spectrometry. Clin Chem 2005;51:872–7.
   PubMed Web of Science ®Google Scholar
• Teshima D, Otsubo K, Kitagawa N, Yoshimura S, Itoh Y, Oishi R. High-performance liquid chromatographic method for mycophenolic acid and its glucuronide in serum and urine. J Clin Pharm Ther 2003;28:17–22.
   PubMed Web of Science ®Google Scholar
• Aresta A, Palmisano F, Zambonin CG, Schena P, Grandaliano G. Simultaneous determination of free mycophenolic acid and its glucuronide in serum of patients under mycophenolate mophetil therapy by ion-pair reversed-phase liquid chromatography with diode array UV detection. J Chromatogr B 2004;810:197–202.
   PubMed Web of Science ®Google Scholar
• Elbarbry FA, Shoker A. Simple high performance liquid chromatographic assay for mycophenolic acid in renal transplant patients. J Pharm Biomed Anal 2007;43:788–92.
   PubMed Web of Science ®Google Scholar
• Indjova D, Kassabova L, Svinarov D. Simultaneous determination of mycophenolic acid and its phenolic glucuronide in human plasma using an isocratic high-performance liquid chromatography procedure. J Chromatogr B Analyt Technol Biomed Life Sci 2005;817:327–30.
   PubMed Web of Science ®Google Scholar
• Weber LT, Shipkova M, Armstrong VW, Wagner N, Schütz E, Mehls O, Zimmerhackl LB, Oellerich M, Tönshoff B. Comparison of the emit immunoassay with HPLC for therapeutic drug monitoring of mycophenolic acid in pediatric renal-transplant recipients on mycophenolate mofetil therapy. Clin Chem 2002;48:517–25.
   PubMed Web of Science ®Google Scholar
• Shipkova M, Schutz E, Besenthal I, Fraunberger P, Wieland E. Investigation of the crossreactivity of mycophenolic acid glucuronide metabolites and of mycophenolate mofetil in the Cedia MPA assay. Ther Drug Monit 2010;32:79–85.
   PubMed Web of Science ®Google Scholar
• Dasgupta A, Johnson M. Positive bias in mycophenolic acid concentrations determined by the CEDIA assay compared to HPLC-UV method: is CEDIA assay suitable for therapeutic drug monitoring of mycophenolic acid?. J Clin Lab Anal 2013;27:77–80.
   PubMed Web of Science ®Google Scholar
• Marquet P, Saint-Marcoux F, Premaud A, Sauvage FL, Jaqz-Aigrain E, Knoop C, Lebranchu Y, Tiberi M, Domke I, Debord J. Performance of the new mycophenolate assay based on IMPDH enzymatic activity for pharmacokinetic investigations and setup of Bayesian estimators in different populations of allograft recipients. Ther Drug Monit 2009;31:443–50.
   PubMed Web of Science ®Google Scholar
• Brandhorst G, Marquet P, Shaw LM, Liebisch G, Schmitz G, Coffing MJ, Domke I, Streit F, Luthe H, Oellerich M. Multicenter evaluation of a new inosine monophosphate dehydrogenase inhibition assay for quantification of total mycophenolic acid in plasma. Ther Drug Monit 2008;30:428–33.
   PubMed Web of Science ®Google Scholar
• Syed M, Srinivas NR. A comprehensive review of the published assays for the quantitation of the immunosuppressant drug mycophenolic acid and its glucuronidated metabolites in biological fluids. Biomed Chromatogr 2016;30:721–48.
   PubMed Web of Science ®Google Scholar
• Kunicki PK, Pawinski T, Boczek A, Was J, Bodnar-Broniarczyk M. A comparison of the immunochemical methods, PETINIA and EMIT, with that of HPLC-UV for the routine monitoring of mycophenolic acid in heart transplant patients. Ther Drug Monit 2015;37:311–8.
   PubMed Web of Science ®Google Scholar
• de Loor H, Naesens M, Verbeke K, Vanrenterghem Y, Kuypers DR. Stability of mycophenolic acid and glucuronide metabolites in human plasma and the impact of deproteinization methodology. Clin Chim Acta 2008;389:87–92.
   PubMed Web of Science ®Google Scholar
• Tracey J, Brown NW, Tredger JM. Optimal storage temperature and matrix before analyzing mycophenolic acid. Ther Drug Monit 2012;34:148–52.
   PubMed Web of Science ®Google Scholar
• Shipkova M, Armstrong VW, Schneider T, Niedmann PD, Schutz E, Wieland E, Oellerich M. Stability of mycophenolic acid and mycophenolic acid glucuronide in human plasma. Clin Chem 1999;45:127–9.
   PubMed Web of Science ®Google Scholar
• Tsina I, Chu F, Hama K, Kaloostian M, Tam YL, Tarnowski T, Wong B. Manual and automated (robotic) high-performance liquid chromatography methods for the determination of mycophenolic acid and its glucuronide conjugate in human plasma. J Chromatogr B Biomed Appl 1996;675:119–29.
   PubMed Web of Science ®Google Scholar
• Shipkova M, Schutz E, Armstrong VW, Niedmann PD, Oellerich M, Wieland E. Determination of the acyl glucuronide metabolite of mycophenolic acid in human plasma by HPLC and Emit. Clin Chem 2000;46:365–72.
   PubMed Web of Science ®Google Scholar
• EMA. Guideline on Bioanalytical Method Validation. London, UK: European Medicine Agency; 2011.
   Google Scholar
• FDA. Draft: Guidance for Industry – Bioanalytical Method Validation. Rockville (MD): Federal Food and Drug Administration; 2013.
   Google Scholar
• Seger C, Shipkova M, Christians U, Billaud EM, Wang P, Holt DW, Brunet M, Kunicki PK, Pawinski T, Langman LJ, Marquet P, Oellerich M, Wieland E, Wallemacq P. Assuring the proper analytical performance of measurement procedures for immunosuppressive drug concentrations in clinical practice: recommendations of the international association of therapeutic drug monitoring and clinical toxicology immunosuppressive drug scientific committee. Ther Drug Monit 2016;38:170–89.
   PubMed Web of Science ®Google Scholar
• Altman DG, Bland JM. Measurement in medicine: the analysis of method comparison studies. The Statistician 1983;32:307–17.
   Google Scholar
• Linnet K. Evaluation of regression procedures for methods comparison studies. Clin Chem 1993;39:424–32.
   PubMed Web of Science ®Google Scholar
• Snyder LR, Kirkland JJ, Glajch JL, Practical HPLC method development. Hoboken (NJ): John Wiley & Sons; 2012.
   Google Scholar
• Zivanovic L, Protic A, Zecevic M, Jocic B, Kostic M. Multicriteria optimization methodology in development of HPLC separation of mycophenolic acid and mycophenolic acid glucuronide in human urine and plasma. J Pharm Biomed Anal 2009;50:640–8.
   PubMed Web of Science ®Google Scholar